Andreas Bergmann
136Patents
13h-index
76Co-inventors
89Inventor score
Filing activity: Jul 8, 1988 → Sep 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6756483B1 | Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections | Physics | 63 | Expired |
| US7132246B2 | Use of soluble cytokeratin-1-fragments in diagnostics and therapy | Physics | 30 | Expired |
| US7157081B2 | Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis | Physics | 30 | Expired |
| US8507210B2 | Detection of bacterial infections in subjects suffering from dyspnea | Physics | 30 | Active |
| US7153662B2 | Inflammation-specific peptides and the uses thereof | Human Necessities | 25 | Expired |
| US8354506B2 | Antibodies for the selective determination of procalcitonin 1-116 | Physics | 20 | Active |
| US7807397B2 | Diagnostic method for disorders using copeptin | Emerging Cross-Sectional Technologies | 19 | Active |
| US8842356B2 | Micromechanical device with temperature stabilization and method for adjusting a defined temperature or a defined temperature course on a micromechanical device | Physics | 18 | Active |
| US8183004B2 | Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections | Physics | 18 | Active |
| US7723492B2 | Method for the detection of sepsis using procalcitonin-3-116 | Physics | 14 | Active |
| US7498139B2 | Method for determining sepsis using pro-ANF | Physics | 14 | Expired |
| US5814461A | Method for the determination of anti-TSH receptor autoantibodies | Physics | 14 | Expired |
| US6537760B1 | Receptor binding assay for detecting TSH-receptor auto-antibodies | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6853113B2 | Interdigital transducer with distibuted excitation | Electricity | 13 | Expired |
| US6777855B2 | Surface wave converter with optimized reflection | Electricity | 13 | Expired |
| US7915002B2 | Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides | Physics | 13 | Active |
| US7972799B2 | Method for determining sepsis using pro-ADM | Physics | 12 | Active |
| US8252544B2 | Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients | Physics | 12 | Active |
| US6992547B2 | Surface acoustic wave arrangement for broadband signal transmission | Electricity | 12 | Expired |
| US8524463B2 | Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP | Physics | 11 | Active |
| US7659075B2 | Method for the diagnosis of sepsis with determination of soluble cytokeratin fragments | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9012151B2 | Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin | Physics | 10 | Active |
| US6313715A | Saw duplexer | Electricity | 10 | Expired |
| US5541116A | Method for the stabilization of endogenous, physiologically active peptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7977072B2 | Sandwich immunoassay for identifying partial proANP peptides | Physics | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.